Ultrasound reverses chemo-resistance in breast cancer stem cell-like cells by altering ABCG2  expression.

In conclusion, this new US-MB treatment condition has clinical potential in breast cancer therapy by targeting BCSCs; thereby holding benefits for breast cancer patients. PMID: 28935760 [PubMed - as supplied by publisher]
Source: Bioscience Reports - Category: Biomedical Science Authors: Tags: Biosci Rep Source Type: research